Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05368389 · ClinicalTrials.gov registry record
Observational Study of Wearable Health Monitoring Device
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 33
- Enrollment target
NCT05368389: Completed study, sponsored by Mayo Clinic.
NCT05368389 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05368389 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the use of Healthdot devices on bariatric patients in the USA. Healthdot is a wearable monitoring device that can collect data on heart rate, respiration rate, posture, and activity. This device can be worn at the hospital and at home. The Healthdot will be able to send data and have good connectivity in a place where there is network coverage(4G/5G).
Primary Outcome
The number of times data is collected successfully from the Healthdot device.
Interventions
- DEVICE Healthdot attachment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2022-11-03 |
| Est. Completion | 2023-06-21 |
What the finished NCT05368389 record still lists
NCT05368389 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Healthdot attachment is the first listed.
NCT05368389 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05368389 about?
NCT05368389 is a clinical study titled "Observational Study of Wearable Health Monitoring Device". The purpose of this study is to better understand the use of Healthdot devices on bariatric patients in the USA. Healthdot is a wearable monitoring device that can collect data on heart rate, respiration rate, posture, and activity. This device can be worn at the hospital and at home. The Healthdot ...
What is the current status of trial NCT05368389?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2022-11-03. Estimated completion is 2023-06-21.
What interventions are being tested in trial NCT05368389?
The interventions under investigation include: Healthdot attachment (DEVICE).
Who is sponsoring clinical trial NCT05368389?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI